EUVIMEDEUVIMED entdecken
Crossref

QuantiFERON Supernatant-Based Host Biomarkers Predicting Progression to Active Tuberculosis Disease Among Household Contacts of Tuberculosis Patients

Evangeline Ann Daniel iD, Kannan Thiruvengadam, Anuradha Rajamanickam, Padmapriyadarsini Chandrasekaran, Sathyamurthi Pattabiraman, Brindha Bhanu, Amsaveni Sivaprakasam, Mandar Paradkar, Vandana Kulkarni, Rajesh Karyakarte, Shri Vijay Bala Yogendra Shivakumar, Vidya Mave und 3 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Evangeline Ann Daniel und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Research in Tuberculosis, Indian Council of Medical Research (ICMR), Chennai, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Latent Tuberculosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The positive predictive value of tuberculin skin test and current generation interferon gamma release assays are very low leading to high numbers needed to treat. Therefore, it is critical to identify new biomarkers with high predictive accuracy to identify individuals bearing high risk of progression to active tuberculosis (TB).

Methods

We used stored QuantiFERON supernatants from 14 household contacts of index TB patients who developed incident active TB during a 2-year follow-up and 20 age and sex-matched non-progressors. The supernatants were tested for an expanded panel of 45 cytokines, chemokines, and growth factors using the Luminex Multiplex Array kit.

Results

We found significant differences in the levels of TB-antigen induced production of several analytes between progressors and non-progressors. Dominance analysis identified 15 key predictive biomarkers based on relative percentage importance. Principal component analysis revealed that these biomarkers could robustly distinguish between the 2 groups. Receiver operating characteristic analysis identified interferon-γ inducible protein (IP)-10, chemokine ligand (CCL)19, interferon (IFN)-γ, interleukin (IL)-1ra, CCL3, and granulocyte-macrophage colony-stimulating factor (GM-CSF) as the most promising predictive markers, with area under the curve (AUC) ≥90. IP-10/CCL19 ratio exhibited maximum sensitivity and specificity (100%) for predicting progression. Through Classification and Regression Tree analysis, a cutoff of 0.24 for IP-10/CCL19 ratio was found to be ideal for predicting short-term risk of progression to TB disease with a positive predictive value of 100 (95% confidence interval [CI] 85.8–100).

Conclusions

The biomarkers identified in this study will pave way for the development of a more accurate test that can identify individuals at high risk for immediate progression to TB disease for targeted intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisLatent TuberculosisHumansChemokine CXCL10Interferon-gamma Release TestsTuberculin TestBiomarkers

Stichwörter der Autor:innen

QuantiFERON supernatantsbiomarkersprogression‌tuberculosis

Substanzen

Chemokine CXCL10Biomarkers

Autor:innen und Institutionen

  • National Institute for Research in Tuberculosis, Indian Council of Medical Research (ICMR), Chennai, India.
  • University of Madras, Chennai, India.
  • International Centre for Excellence in Research-National Institute for Research in Tuberculosis, Indian Council of Medical Research (ICMR), Chennai, India.
  • Byramjee Jeejeebhoy Government Medical College, Johns Hopkins Clinical Research Site, Pune, India.
  • Johns Hopkins Center for Infectious Diseases in India, Pune, India.
  • Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India.

ORCID-Profile: Evangeline Ann Daniel

Zitieren

APA

Daniel, E. A., Thiruvengadam, K., Rajamanickam, A., Chandrasekaran, P., Pattabiraman, S., Bhanu, B., Sivaprakasam, A., Paradkar, M., Kulkarni, V., Karyakarte, R., Shivakumar, S. V. B. Y., Mave, V., Gupta, A., Babu, S., & Hanna, L. E. (2023). QuantiFERON Supernatant-Based Host Biomarkers Predicting Progression to Active Tuberculosis Disease Among Household Contacts of Tuberculosis Patients. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac979

Vancouver

Daniel EA, Thiruvengadam K, Rajamanickam A, Chandrasekaran P, Pattabiraman S, Bhanu B, et al. QuantiFERON Supernatant-Based Host Biomarkers Predicting Progression to Active Tuberculosis Disease Among Household Contacts of Tuberculosis Patients. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac979

BibTeX
@article{Daniel2023,
  author = {Daniel, Evangeline Ann and Thiruvengadam, Kannan and Rajamanickam, Anuradha and Chandrasekaran, Padmapriyadarsini and Pattabiraman, Sathyamurthi and Bhanu, Brindha and Sivaprakasam, Amsaveni and Paradkar, Mandar and Kulkarni, Vandana and Karyakarte, Rajesh and Shivakumar, Shri Vijay Bala Yogendra and Mave, Vidya and Gupta, Amita and Babu, Subash and Hanna, Luke Elizabeth},
  title = {QuantiFERON Supernatant-Based Host Biomarkers Predicting Progression to Active Tuberculosis Disease Among Household Contacts of Tuberculosis Patients},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac979}
}
Kostenlos starten →